You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HU-045

Showing 1 - 25 of 193
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glabellar Lines Trial (HU-045, Xeomin®)

Not yet recruiting
  • Glabellar Lines
  • (no location specified)
Mar 25, 2022

Immune Tolerance Breakdown in HU-autoimmunity

Active, not recruiting
  • Immune Tolerance
  • Description of clinical, immunological and tumor features of patients harboring Hu Abs
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Feb 23, 2023

Hyperuricemia, Gout Trial in Minneapolis (Vitamin C)

Recruiting
  • Hyperuricemia
  • Gout
  • Vitamin C
  • Minneapolis, Minnesota
    University of Minnesota
Jan 9, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial (Favipiravir HU 200 mg hard capsules, Placebo HU)

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • Favipiravir HU 200 mg hard capsules
  • Placebo HU
  • Szeged, Hungary
    University of Szeged - Internal Medicine
Nov 4, 2022

Pancreatitis, Chronic, Pancreatic Duct Stone Trial (Lactated ringers solution, normal saline)

Not yet recruiting
  • Pancreatitis, Chronic
  • Pancreatic Duct Stone
  • Lactated ringers solution
  • normal saline
  • (no location specified)
Mar 15, 2023

Sickle-Cell Anaemia Trial in Kinshasa (Hydroxyurea)

Completed
  • Sickle-Cell Anaemia
  • Kinshasa, Congo, The Democratic Republic of the
    University of Kinshasa
Dec 27, 2022

Couple User Preferences in Dual Purpose Prevention Products

Completed
  • HIV Prevention
  • Contraception Behavior
    • Kampala, Uganda
    • +1 more
    Oct 11, 2022

    Enablers and Barriers to Hydroxyurea Use for Sickle Cell Disease

    Recruiting
    • Sickle Cell Disease
    • questionnaires (surveys)
    • Kingston, Saint Andrew, Jamaica
      Sickle Cell Unit - Caribbean Institute for Health Research
    Jun 16, 2023

    Exploring Adherence Monitoring in Sickle Cell Disease

    Active, not recruiting
    • Sickle Cell Disease
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Aug 19, 2022

      Polycythemia Vera Trial (Hydroxyurea)

      Not yet recruiting
      • Polycythemia Vera
      • (no location specified)
      May 2, 2023

      SGA, Turner Syndrome, Noonan Syndrome, ISS Trial (Somapacitan, Norditropin®)

      Recruiting
      • SGA, Turner Syndrome, Noonan Syndrome, ISS
      • Birmingham, Alabama
      • +163 more
      Feb 2, 2023

      Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)

      Recruiting
      • Sickle Cell Disease
      • +4 more
      • CTX001
      • Philadelphia, Pennsylvania
      • +3 more
      Jan 24, 2023

      Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)

      Terminated
      Has Results
      • Sickle Cell Disease
      • Thalassemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Feb 18, 2022

      Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

      Active, not recruiting
      • Polycythemia Vera
      • Ropeginterferon alfa-2b
      • Beijing, China
      • +13 more
      Aug 1, 2022

      ESCORT-HU Extension: European Sickle Cell Disease Cohort -

      Recruiting
      • Sickle Cell Disease
      • Amiens, France
      • +78 more
      Mar 24, 2022

      Malignant Tumor, Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen)

      Recruiting
      • Malignant Tumor
      • Diarrhea
      • Xiao Chai Hu Tang (XCHT)
      • +2 more
      • Guangzhou, Guangdong, China
        Guangdong Provincial Hospital of Chinese Medicine
      Aug 11, 2022

      Sickle Cell Disease Trial in United States

      Recruiting
      • Sickle Cell Disease
        • Peoria, Illinois
        • +5 more
        Nov 15, 2022

        Surgical Site Infection, Complication,Postoperative, Surgical Wound Infection Trial in Oviedo (negative preassure wound therapy)

        Completed
        • Surgical Site Infection
        • +3 more
        • negative preassure wound therapy
        • Oviedo, Asturias, Spain
          María Moreno Gijón
        Jul 8, 2022

        Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

        Not yet recruiting
        • Esophageal Cancer
        • +3 more
        • Beijing, Beijing, China
          Department of Radiation Oncology, Cancer Institute and Hospital,
        Jul 12, 2023

        Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)

        Recruiting
        • Sickle Cell Disease
        • NDec - oral decitabine-tetrahydrouridine
        • +2 more
        • Oakland, California
        • +39 more
        Jan 24, 2023

        Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

        Active, not recruiting
        • Myelofibrosis
        • Chronic Myelomonocytic Leukemia
        • Duarte, California
        • +9 more
        Jan 24, 2023

        Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

        Recruiting
        • Metastatic Non-Small Cell Lung Carcinoma
        • Pembrolizumab Injection
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Nov 6, 2022

        Sickle Cell Disease, Sickle B+ Thalassemia, Sickle Beta Zero Thalassemia Trial in Chicago (HU-Go app)

        Completed
        • Sickle Cell Disease
        • +3 more
        • HU-Go app
        • Chicago, Illinois
          Ann & Robert H Lurie Children's Hospital of Chicago
        Jul 27, 2021

        Sickle Cell Disease Trial in United States (HABIT Intervention)

        Completed
        • Sickle Cell Disease
        • HABIT Intervention
        • Bronx, New York
        • +3 more
        Mar 7, 2022

        HIV Trial in United States (Indinavir sulfate, Lamivudine/Zidovudine, Hydroxyurea)

        Completed
        • HIV Infections
        • Indinavir sulfate
        • +6 more
        • Birmingham, Alabama
        • +33 more
        Oct 27, 2021